Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Johnson & Johnson Given Control of Emergent BioSolutions Factory That Botched Its Coronavirus Vaccine


The U.S. government has given Johnson & Johnson (NYSE: JNJ) control of a Baltimore production facility operated by Emergent BioSolutions (NYSE: EBS).

The move is the latest development in a controversy over Emergent's production of Johnson & Johnson's coronavirus vaccine, the latest of three to receive Emergency Use Authorization from the Food and Drug Administration. Last week, Emergent admitted that it manufactured a batch of the vaccine in the Baltimore facility that "did not meet specifications and our rigorous quality standards."

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
JNJ
Share

Comments